Ionis Pharmaceuticals (IONS) Shares Outstanding (2009 - 2026)

Ionis Pharmaceuticals' Shares Outstanding (Entity) history runs 18 years deep, the most recent figure standing at $165.6 million for Q2 2026.

• In Q2 2026, Shares Outstanding (Entity) rose 4.05% year-over-year to $165.6 million; the TTM figure through Jun 2026 stood at $165.6 million (up 4.05% YoY), while the FY2025 annual figure was $163.3 million, up 3.42% from the prior year.
• Shares Outstanding (Entity) for Q2 2026 stood at $165.6 million, roughly flat from $165.9 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $165.9 million in Q1 2026, with the low at $141.8 million in Q1 2022.
• The 5-year median for Shares Outstanding (Entity) is $145.9 million (2024), against an average of $151.3 million.
• The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Entity) advanced 0.57% in 2022, then grew 10.06% in 2024.
• Ionis Pharmaceuticals' Shares Outstanding (Entity) stood at $142.1 million in 2022, then advanced by 1.61% to $144.3 million in 2023, then climbed by 9.4% to $157.9 million in 2024, then climbed by 3.42% to $163.3 million in 2025, then advanced by 1.43% to $165.6 million in 2026.
• Business Quant data shows IONS's Shares Outstanding (Entity) at $165.6 million in Q2 2026, $165.9 million in Q1 2026, and $163.3 million in Q4 2025.